145 related articles for article (PubMed ID: 26666714)
1. [Mutations of epigenetic regulator genes and myeloid malignancies].
Muto T; Sashida G; Oshima M; Iwama A
Rinsho Ketsueki; 2015 Nov; 56(11):2287-94. PubMed ID: 26666714
[TBL] [Abstract][Full Text] [Related]
2. The role of mutations in epigenetic regulators in myeloid malignancies.
Woods BA; Levine RL
Immunol Rev; 2015 Jan; 263(1):22-35. PubMed ID: 25510269
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic Modifiers in Myeloid Malignancies: The Role of Histone Deacetylase Inhibitors.
Ungerstedt JS
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30304859
[TBL] [Abstract][Full Text] [Related]
4. Chromatin regulator Asxl1 loss and Nf1 haploinsufficiency cooperate to accelerate myeloid malignancy.
Zhang P; He F; Bai J; Yamamoto S; Chen S; Zhang L; Sheng M; Zhang L; Guo Y; Man N; Yang H; Wang S; Cheng T; Nimer SD; Zhou Y; Xu M; Wang QF; Yang FC
J Clin Invest; 2018 Dec; 128(12):5383-5398. PubMed ID: 30226831
[TBL] [Abstract][Full Text] [Related]
5. [Epigenetic dysregulation in myelodysplastic syndromes].
Sashida G
Rinsho Ketsueki; 2017; 58(10):1809-1817. PubMed ID: 28978819
[TBL] [Abstract][Full Text] [Related]
6. [Research on molecular markers for epigenetic changes in myeloid malignancies].
Li L; Sun XM
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Dec; 30(6):687-92. PubMed ID: 24327148
[TBL] [Abstract][Full Text] [Related]
7. [Myeloid neoplasms in the World Health Organization 2016 classification].
Asou N
Rinsho Ketsueki; 2017; 58(10):2178-2187. PubMed ID: 28978863
[TBL] [Abstract][Full Text] [Related]
8. Acute myeloid leukemia: therapeutic impact of epigenetic drugs.
Altucci L; Clarke N; Nebbioso A; Scognamiglio A; Gronemeyer H
Int J Biochem Cell Biol; 2005 Sep; 37(9):1752-62. PubMed ID: 15964234
[TBL] [Abstract][Full Text] [Related]
9. Myeloid malignancies: mutations, models and management.
Murati A; Brecqueville M; Devillier R; Mozziconacci MJ; Gelsi-Boyer V; Birnbaum D
BMC Cancer; 2012 Jul; 12():304. PubMed ID: 22823977
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic aberrations in acute myeloid leukemia: Early key events during leukemogenesis.
Eriksson A; Lennartsson A; Lehmann S
Exp Hematol; 2015 Aug; 43(8):609-24. PubMed ID: 26118500
[TBL] [Abstract][Full Text] [Related]
11. Cytosine modifications in myeloid malignancies.
Meldi KM; Figueroa ME
Pharmacol Ther; 2015 Aug; 152():42-53. PubMed ID: 25956466
[TBL] [Abstract][Full Text] [Related]
12. Insight into the molecular pathogenesis of myeloid malignancies.
Haferlach T; Bacher U; Haferlach C; Kern W; Schnittger S
Curr Opin Hematol; 2007 Mar; 14(2):90-7. PubMed ID: 17255785
[TBL] [Abstract][Full Text] [Related]
13. Genetic and epigenetic pathways in myelodysplastic syndromes: A brief overview.
Jhanwar SC
Adv Biol Regul; 2015 May; 58():28-37. PubMed ID: 25499150
[TBL] [Abstract][Full Text] [Related]
14. Somatic mutations and epigenetic abnormalities in myelodysplastic syndromes.
Itzykson R; Kosmider O; Fenaux P
Best Pract Res Clin Haematol; 2013 Dec; 26(4):355-64. PubMed ID: 24507812
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic dysregulation of hematopoietic stem cells and preleukemic state.
Kunimoto H; Nakajima H
Int J Hematol; 2017 Jul; 106(1):34-44. PubMed ID: 28555413
[TBL] [Abstract][Full Text] [Related]
16. [Genetic and epigenetic abnormalities in myeloproliferative neoplasms].
Kameda T; Shide K; Shimoda K
Rinsho Ketsueki; 2015 Jun; 56(6):614-22. PubMed ID: 26256870
[TBL] [Abstract][Full Text] [Related]
17. The role of mutations in epigenetic regulators in myeloid malignancies.
Shih AH; Abdel-Wahab O; Patel JP; Levine RL
Nat Rev Cancer; 2012 Sep; 12(9):599-612. PubMed ID: 22898539
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic deregulation in myeloid malignancies.
Meldi KM; Figueroa ME
Transl Res; 2015 Jan; 165(1):102-14. PubMed ID: 24813528
[TBL] [Abstract][Full Text] [Related]
19. RUNX1 meets MLL: epigenetic regulation of hematopoiesis by two leukemia genes.
Koh CP; Wang CQ; Ng CE; Ito Y; Araki M; Tergaonkar V; Huang G; Osato M
Leukemia; 2013 Sep; 27(9):1793-802. PubMed ID: 23817177
[TBL] [Abstract][Full Text] [Related]
20. New strategies for relapsed acute myeloid leukemia: fertile ground for translational research.
Dinner SN; Giles FJ; Altman JK
Curr Opin Hematol; 2014 Mar; 21(2):79-86. PubMed ID: 24419335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]